In breast cancer, ovarian carcinoma and in neuroendocrine tumours, targeting sortilin has been reported to inhibit tumour metastasis and to promote tumour cell apoptosis; this observation underscores the bad prognosis linked to a high level of sortilin expression.21, 22, 23, 24. The gene discussed is SORT1; the disease is neuroendocrine neoplasm.